Kseniia Ievleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kseniia Ievleva has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Larisa Victorovna Suturina
Scientific centre for Family Health and Human Reproduction Problems
4 shared publications - Alina Valerievna Atalyan
Scientific centre for Family Health and Human Reproduction Problems
3 shared publications - Iana Nadeliaeva
Scientific Center for Family Health and Human Reproduction Problems, 664003 Irkutsk, Russia
3 shared publications - Irina Egorova
Scientific Center for Family Health and Human Reproduction Problems, 664003 Irkutsk, Russia
3 shared publications - Irina N. Danusevich
Scientific centre for Family Health and Human Reproduction Problems
3 shared publications - Lyudmila M. Lazareva
Scientific centre for Family Health and Human Reproduction Problems
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Metabolic Syndrome in a Multiethnic Population of Peri- and Postmenopausal Women
Aim. To determine ethnic-specific differences in the prevalence and phenotype of metabolic syndrome (MS) during the peri- and postmenopause period in women of Caucasian, Asian, and mixed-ethnicity women. Design. Multicenter, cross-sectional study. Materials and methods. The study was conducted in the city of Irkutsk and the settlement of Bokhan (Irkutsk region), as well as in the city of Ulan-Ude (Republic of Buryatia) from 2016 to 2019. The study included 1 250 peri/postmenopausal women (mean age 51.53 ± 7.95 years) receiving annual routine health check-ups. The participants were divided into three groups: 790 (63.20%) Caucasian, 387 (30.96%) Asian, and 73 (5.84%) women of mixed-ethnicity women. Evaluations included a questionnaire, general clinical examination (with waist circumference and blood pressure measurements), gynecological examinations, and assessment of biochemical markers required for MS verification: high-density lipoprotein cholesterol (HDL-C), triacylglycerides and fasting glucose levels. Results. The overall prevalence of MS in the study cohort was 41.8% (523/1 250). The syndrome was significantly more common among Caucasian women (46.2%, 365/790) and those of mixed ethnicity (42.5%, 31/73), compared with the Asian cohort (32.8%, 127/387); p < 0.001. The most common MS components in all groups were increased waist circumference, arterial hypertension, and low HDL-C levels. Regarding the phenotypic structure of MS, a combination of three criteria was identified in the majority of patients — 70.6% (369/523). The presence of all five components (complete phenotype; 8.2%, 30/365), as well as a higher prevalence of fasting hyperglycaemia (53.7%, 196/365 vs. 38.6%, 49/127 in Asian women; p = 0.003) was observed predominantly in the Caucasian group. Conclusion. Significant ethnic differences in the prevalence and phenotypic structure of MS during the peri- and postmenopause were established, with the highest overall detection rate of the syndrome, its complete phenotype, and hyperglycaemia observed in Caucasian women. These findings support the need for developing ethnic-specific approaches to screening for metabolic disorders and preventing cardiometabolic diseases. Keywords: metabolic syndrome, perimenopause, postmenopause, ethnicity
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessMetabolic Syndrome in a Multiethnic Population of Peri- and Postmenopausal Women
Aim. To determine ethnic-specific differences in the prevalence and phenotype of metabolic syndrome (MS) during the peri- and postmenopause period in women of Caucasian, Asian, and mixed-ethnicity women. Design. Multicenter, cross-sectional study. Materials and methods. The study was conducted in the city of Irkutsk and the settlement of Bokhan (Irkutsk region), as well as in the city of Ulan-Ude (Republic of Buryatia) from 2016 to 2019. The study included 1 250 peri/postmenopausal women (mean age 51.53 ± 7.95 years) receiving annual routine health check-ups. The participants were divided into three groups: 790 (63.20%) Caucasian, 387 (30.96%) Asian, and 73 (5.84%) women of mixed-ethnicity women. Evaluations included a questionnaire, general clinical examination (with waist circumference and blood pressure measurements), gynecological examinations, and assessment of biochemical markers required for MS verification: high-density lipoprotein cholesterol (HDL-C), triacylglycerides and fasting glucose levels. Results. The overall prevalence of MS in the study cohort was 41.8% (523/1 250). The syndrome was significantly more common among Caucasian women (46.2%, 365/790) and those of mixed ethnicity (42.5%, 31/73), compared with the Asian cohort (32.8%, 127/387); p < 0.001. The most common MS components in all groups were increased waist circumference, arterial hypertension, and low HDL-C levels. Regarding the phenotypic structure of MS, a combination of three criteria was identified in the majority of patients — 70.6% (369/523). The presence of all five components (complete phenotype; 8.2%, 30/365), as well as a higher prevalence of fasting hyperglycaemia (53.7%, 196/365 vs. 38.6%, 49/127 in Asian women; p = 0.003) was observed predominantly in the Caucasian group. Conclusion. Significant ethnic differences in the prevalence and phenotypic structure of MS during the peri- and postmenopause were established, with the highest overall detection rate of the syndrome, its complete phenotype, and hyperglycaemia observed in Caucasian women. These findings support the need for developing ethnic-specific approaches to screening for metabolic disorders and preventing cardiometabolic diseases. Keywords: metabolic syndrome, perimenopause, postmenopause, ethnicity
- Open Access
- 22 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 673
Ovarian Morphology in Non-Hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women from a Multi-Ethnic Unselected Siberian Population
Polycystic ovary syndrome (PCOS) is a highly prevalent disorder in women, and its diagnosis rests on three principal features: ovulatory/menstrual dysfunction, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology (PCOM). Currently, data on age- and ethnicity-dependent features of PCOM remain insufficient. We aimed to estimate ethnicity- and age-dependent differences in ovarian volume (OV) and follicle number per ovary (FNPO) in a healthy, medically unbiased population of Caucasian and Asian premenopausal women, who participated in the cross-sectional Eastern Siberia PCOS epidemiology and phenotype (ESPEP) study (ClinicalTrials.gov ID: NCT05194384) in 2016–2019. The study population consisted of 408 non-hirsute, normo-androgenic, eumenorrheic premenopausal women aged 18–44 years. All participants underwent a uniform evaluation including a review of their medical history and a physical examination, blood sampling, and pelvic ultrasonography. The statistical analysis included non-parametric tests and the estimation of the upper normal limits (UNLs) by 98th percentiles for OV and FNPO. In the total study population, the upper OV percentiles did not differ by ethnicity or age group. By contrast, the UNL of FNPO was higher in Caucasian women than in Asian women, and women aged <35 years demonstrated a higher UNL of FNPO compared to older women. In summary, these data suggest that the estimation of FNPO, but not OV, should take into account the ethnicity and age of the individual in estimating the presence of PCOM.
- 22 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 673
Open AccessOvarian Morphology in Non-Hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women from a Multi-Ethnic Unselected Siberian Population
Polycystic ovary syndrome (PCOS) is a highly prevalent disorder in women, and its diagnosis rests on three principal features: ovulatory/menstrual dysfunction, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology (PCOM). Currently, data on age- and ethnicity-dependent features of PCOM remain insufficient. We aimed to estimate ethnicity- and age-dependent differences in ovarian volume (OV) and follicle number per ovary (FNPO) in a healthy, medically unbiased population of Caucasian and Asian premenopausal women, who participated in the cross-sectional Eastern Siberia PCOS epidemiology and phenotype (ESPEP) study (ClinicalTrials.gov ID: NCT05194384) in 2016–2019. The study population consisted of 408 non-hirsute, normo-androgenic, eumenorrheic premenopausal women aged 18–44 years. All participants underwent a uniform evaluation including a review of their medical history and a physical examination, blood sampling, and pelvic ultrasonography. The statistical analysis included non-parametric tests and the estimation of the upper normal limits (UNLs) by 98th percentiles for OV and FNPO. In the total study population, the upper OV percentiles did not differ by ethnicity or age group. By contrast, the UNL of FNPO was higher in Caucasian women than in Asian women, and women aged <35 years demonstrated a higher UNL of FNPO compared to older women. In summary, these data suggest that the estimation of FNPO, but not OV, should take into account the ethnicity and age of the individual in estimating the presence of PCOM.
- Open Access
- 14 February 2024
- Published by MDPI AG in Preprints.org
Ovarian Morphology in Non-hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women From a Multi-ethnic Unselected Siberian Population
Keywords: pelvic ultrasound, follicle number per ovary, FNPO, ovarian volume, PCOM, upper normal limits, referral population
- 14 February 2024
- Published by MDPI AG in Preprints.org
Open AccessOvarian Morphology in Non-hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women From a Multi-ethnic Unselected Siberian Population
Keywords: pelvic ultrasound, follicle number per ovary, FNPO, ovarian volume, PCOM, upper normal limits, referral population
- Open Access
Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
Abnormalities in gut microbiota diversity are considered important mechanisms in metabolic disorders in polycystic ovarian syndrome (PCOS). However, the data on the association of these disorders with the PCOS phenotype remain controversial. The objectives of this study were to estimate the alpha diversity of the gut microbiota of healthy women and PCOS patients depending on phenotype. The study participants (184 premenopausal women: 63 with PCOS, 121 without PCOS) were recruited during the annual employment assessment in the Irkutsk Region and the Buryat Republic (Russia) in 2016–2019. For PCOS diagnosis, we used the Rotterdam (2003) criteria and definitions of PCOS phenotypes. Five indexes of alpha diversity (ASV, Shannon, Simpson, Chao, and ACE) were estimated for the gut microbiota in all participants using amplicon metasequencing. As a result, two out of five alpha diversity indexes showed a statistical difference between the non-PCOS and PCOS groups. We did not find a significant difference in the alpha diversity of gut microbiota in the subgroups of women with hyperandrogenic PCOS phenotypes vs non-androgenic phenotype D and the group of women with the presence of only one of the PCOS criteria. Nevertheless, “classic” PCOS phenotypes demonstrated the most significant decrease in alpha diversity compared with healthy women without any signs of PCOS.
Open AccessPolycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
Abnormalities in gut microbiota diversity are considered important mechanisms in metabolic disorders in polycystic ovarian syndrome (PCOS). However, the data on the association of these disorders with the PCOS phenotype remain controversial. The objectives of this study were to estimate the alpha diversity of the gut microbiota of healthy women and PCOS patients depending on phenotype. The study participants (184 premenopausal women: 63 with PCOS, 121 without PCOS) were recruited during the annual employment assessment in the Irkutsk Region and the Buryat Republic (Russia) in 2016–2019. For PCOS diagnosis, we used the Rotterdam (2003) criteria and definitions of PCOS phenotypes. Five indexes of alpha diversity (ASV, Shannon, Simpson, Chao, and ACE) were estimated for the gut microbiota in all participants using amplicon metasequencing. As a result, two out of five alpha diversity indexes showed a statistical difference between the non-PCOS and PCOS groups. We did not find a significant difference in the alpha diversity of gut microbiota in the subgroups of women with hyperandrogenic PCOS phenotypes vs non-androgenic phenotype D and the group of women with the presence of only one of the PCOS criteria. Nevertheless, “classic” PCOS phenotypes demonstrated the most significant decrease in alpha diversity compared with healthy women without any signs of PCOS.